Effect of Cilostazol on Preventing Paclitaxel ‐Induced Neuropathy in Patients with Breast Cancer: A Randomized Controlled Trial

ConclusionAdjunctive use of cilostazol may be considered as a novel option that might reduce the incidence of paclitaxel-induced peripheral neuropathy and improve the patients ’ QoL. Future larger clinical trials are warranted to confirm these findings.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Tags: RESEARCH ARTICLE Source Type: research